Astrazeneca plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| INVESTOR AB | 08/14/2026 | 51.59 M | $9.78 B | 0.00% | 3.33% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 45.39 M | $8.47 B | 0.77% | 2.93% |
| CAPITAL INTERNATIONAL INVESTORS | 08/12/2026 | 34.58 M | $6.49 B | 0.53% | 2.23% |
| NORGES BANK | 08/12/2026 | 33.86 M | $6.33 B | 100.00% | 2.19% |
| CAPITAL WORLD INVESTORS | 08/12/2026 | 30.08 M | $5.63 B | 6.41% | 1.94% |
| FMR LLC | 08/13/2026 | 28.90 M | $5.42 B | -2.39% | 1.87% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 28.54 M | $5.36 B | 20.15% | 1.84% |
| LEGAL & GENERAL GROUP PLC | 08/14/2026 | 25.75 M | $4.82 B | -0.39% | 1.66% |
| JPMORGAN CHASE & CO | 08/12/2026 | 19.20 M | $3.67 B | 3.30% | 1.24% |
| VANGUARD ASSET MANAGEMENT, LTD | 08/13/2026 | 18.71 M | $3.49 B | 0.96% | 1.21% |
| PRIMECAP MANAGEMENT CO/CA/ | 08/14/2026 | 18.10 M | $3.43 B | -0.65% | 1.17% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 17.69 M | $3.35 B | -7.18% | 1.14% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 16.62 M | $3.15 B | -14.74% | 1.07% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 16.51 M | $3.11 B | -7.20% | 1.07% |
| AMUNDI | 08/11/2026 | 16.42 M | $3.11 B | 6.74% | 1.06% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 13.29 M | $2.48 B | 0.73% | 0.86% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 12.64 M | $2.40 B | 4.21% | 0.82% |
| JUPITER TOPCO LLC | 08/14/2026 | 11.87 M | $2.22 B | 100.00% | 0.77% |
| DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 08/14/2026 | 11.72 M | $2.19 B | -9.41% | 0.76% |
| FISHER ASSET MANAGEMENT, LLC | 08/04/2026 | 11.15 M | $2.11 B | 2.77% | 0.72% |
| AVIVA PLC | 08/13/2026 | 10.90 M | $2.04 B | -1.70% | 0.70% |
| ROYAL BANK OF CANADA | 08/14/2026 | 10.43 M | $1.98 B | 0.40% | 0.67% |
| INVESCO LTD. | 08/14/2026 | 10.18 M | $1.93 B | 0.73% | 0.66% |
| ROYAL LONDON ASSET MANAGEMENT LTD | 08/13/2026 | 10.16 M | $1.93 B | -1.35% | 0.66% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 9.74 M | $1.85 B | -8.14% | 0.63% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 08/13/2026 | 9.36 M | $1.75 B | 26.08% | 0.60% |
| RATHBONES GROUP PLC | 07/23/2026 | 7.98 M | $1.49 B | -0.94% | 0.52% |
| MORGAN STANLEY | 08/13/2026 | 7.86 M | $1.49 B | 12.77% | 0.51% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 08/13/2026 | 7.54 M | $1.41 B | -1.16% | 0.49% |
| NUVEEN, LLC | 08/11/2026 | 7.18 M | $1.35 B | 5.95% | 0.46% |
| SANDERS CAPITAL, LLC | 08/10/2026 | 6.99 M | $1.32 B | -1.12% | 0.45% |
| ALLIANZ ASSET MANAGEMENT GMBH | 08/14/2026 | 6.83 M | $1.32 B | 4.60% | 0.44% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 6.75 M | $1.28 B | 1.29% | 0.44% |
| BARCLAYS PLC | 08/14/2026 | 6.59 M | $1.25 B | 20.04% | 0.43% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 6.10 M | $1.15 B | 6.06% | 0.39% |
| SWISS NATIONAL BANK | 08/11/2026 | 5.93 M | $1.11 B | -3.89% | 0.38% |
| SEB ASSET MANAGEMENT AB | 08/04/2026 | 5.74 M | $1.08 B | -3.66% | 0.37% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 08/13/2026 | 5.31 M | $1.00 B | 14.07% | 0.34% |
| UBS GROUP AG | 08/13/2026 | 5.30 M | $1.00 B | -11.43% | 0.34% |
| CAISSE DES DEPOTS ET CONSIGNATIONS | 07/24/2026 | 5.03 M | $942.10 M | 3.11% | 0.33% |
| CLEARBRIDGE INVESTMENTS, LLC | 08/13/2026 | 5.02 M | $952.18 M | -2.70% | 0.32% |
| CITIGROUP INC | 08/03/2026 | 4.90 M | $916.20 M | 32.12% | 0.32% |
| FIL LTD | 08/13/2026 | 4.49 M | $840.25 M | -3.49% | 0.29% |
| M&G PLC | 08/06/2026 | 4.48 M | $838.18 M | 6.62% | 0.29% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 4.35 M | $857.01 M | -17.69% | 0.28% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 08/12/2026 | 4.20 M | $787.34 M | -8.97% | 0.27% |
| DEKABANK DEUTSCHE GIROZENTRALE | 08/05/2026 | 3.78 M | $731.96 M | 0.00% | 0.24% |
| CIBC BANCORP USA INC. | 08/13/2026 | 3.77 M | $680.75 M | -17.91% | 0.24% |
| CREDIT AGRICOLE S A | 08/14/2026 | 3.69 M | $700.49 M | 24.07% | 0.24% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 08/14/2026 | 3.67 M | $686.86 M | -4.45% | 0.24% |
Astrazeneca plc institutional Ownership - FAQ's
During the previous two years, 2061 institutional investors and hedge funds held shares of Astrazeneca plc. The most heavily invested institutionals were:
INVESTOR AB: 51.59 M
VANGUARD CAPITAL MANAGEMENT LLC: 45.39 M
Capital International Investors: 34.58 M
NORGES BANK: 33.86 M
Capital World Investors: 30.08 M
FMR LLC: 28.9 M
52.11% of Astrazeneca plc stock is owned by institutional investors.
Institutional investors have bought a total of 899.48 M shares in the last 24 months. This purchase volume represents approximately $175.35 B in transactions.